211 related articles for article (PubMed ID: 32561332)
21. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Iwamoto M; Nakatani Y; Fugo K; Kishimoto T; Kiyokawa T
Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546
[TBL] [Abstract][Full Text] [Related]
22. Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Yamashita Y; Nagasaka T; Naiki-Ito A; Sato S; Suzuki S; Toyokuni S; Ito M; Takahashi S
Mod Pathol; 2015 Jan; 28(1):111-7. PubMed ID: 24721826
[TBL] [Abstract][Full Text] [Related]
23. Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison.
Gilcrease MZ; Delgado R; Vuitch F; Albores-Saavedra J
Hum Pathol; 1998 Dec; 29(12):1451-6. PubMed ID: 9865832
[TBL] [Abstract][Full Text] [Related]
24. Nephrogenic Adenoma of the Prostatic Urethra Mimicking Prostatic and Bladder Carcinomas.
Beeter MC; Fazili T; Yeh YA
Cureus; 2023 Mar; 15(3):e35998. PubMed ID: 37041930
[TBL] [Abstract][Full Text] [Related]
25. PAX2: a reliable marker for nephrogenic adenoma.
Tong GX; Melamed J; Mansukhani M; Memeo L; Hernandez O; Deng FM; Chiriboga L; Waisman J
Mod Pathol; 2006 Mar; 19(3):356-63. PubMed ID: 16400326
[TBL] [Abstract][Full Text] [Related]
26. Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Ueno T; Linder S; Elmberger G
Br J Cancer; 2003 Apr; 88(8):1229-33. PubMed ID: 12698189
[TBL] [Abstract][Full Text] [Related]
27. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Mukhopadhyay S; Katzenstein AL
Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
[TBL] [Abstract][Full Text] [Related]
28. PAX8 positivity in nested variant of urothelial carcinoma: a potential diagnostic pitfall.
Legesse T; Matoso A; Epstein JI
Hum Pathol; 2019 Dec; 94():11-15. PubMed ID: 31669177
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma.
Li Q; Zeng X; Cheng X; Zhang J; Ji J; Wang J; Xiong K; Qi Q; Huang W
Int J Clin Exp Pathol; 2015; 8(7):8305-10. PubMed ID: 26339401
[TBL] [Abstract][Full Text] [Related]
30. Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.
Kim MY; Go H; Koh J; Lee K; Min HS; Kim MA; Jeon YK; Lee HS; Moon KC; Park SY; Kim WH; Chung DH
Histopathology; 2014 Aug; 65(2):195-206. PubMed ID: 24479710
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Jönsson P; Mattsson JSM; Botling J; Micke P; Brunnström H
Hum Pathol; 2019 Feb; 84():221-230. PubMed ID: 30389437
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3.
McDaniel AS; Chinnaiyan AM; Siddiqui J; McKenney JK; Mehra R
Am J Surg Pathol; 2014 Dec; 38(12):1664-71. PubMed ID: 24921643
[TBL] [Abstract][Full Text] [Related]
33. Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
Peat TJ; Edmondson EF; Miller MA; DuSold DM; Ramos-Vara JA
Vet Pathol; 2017 Jul; 54(4):588-594. PubMed ID: 28346124
[TBL] [Abstract][Full Text] [Related]
34. GATA3 expression in clear cell adenocarcinoma of the lower urinary tract: a potential diagnostic pitfall.
Akgul M; Humble R; Osme A; Yuce S; Kocak EN; Najafzadeh P; Sangoi A; Pattnaik N; Mishra S; Sharma S; Shaker N; Kaushal S; Baisakh M; Lightle AR; Balzer BL; Xiao GQ; MacLennan GT; Osunkoya AO; Parwani A; Cheng L; Bellizzi A; Mohanty SK
Diagn Pathol; 2022 Nov; 17(1):87. PubMed ID: 36320040
[TBL] [Abstract][Full Text] [Related]
35. Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma.
Herawi M; Drew PA; Pan CC; Epstein JI
Hum Pathol; 2010 Apr; 41(4):594-601. PubMed ID: 20060152
[TBL] [Abstract][Full Text] [Related]
36. Clear cell adenocarcinoma of urinary bladder and urethra: another urinary tract lesion immunoreactive for P504S.
Sun K; Huan Y; Unger PD
Arch Pathol Lab Med; 2008 Sep; 132(9):1417-22. PubMed ID: 18788852
[TBL] [Abstract][Full Text] [Related]
37. A word of caution regarding napsin A expression in squamous cell carcinomas of the lung.
Ordóñez NG
Am J Surg Pathol; 2012 Mar; 36(3):396-401. PubMed ID: 22198009
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry in diagnostic surgical pathology of the prostate.
Hameed O; Humphrey PA
Semin Diagn Pathol; 2005 Feb; 22(1):88-104. PubMed ID: 16512601
[TBL] [Abstract][Full Text] [Related]
39. Napsin A Expression in Human Tumors and Normal Tissues.
Weidemann S; Böhle JL; Contreras H; Luebke AM; Kluth M; Büscheck F; Hube-Magg C; Höflmayer D; Möller K; Fraune C; Bernreuther C; Rink M; Simon R; Menz A; Hinsch A; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Burandt E; Krech R; Dum D; Krech T; Marx A; Minner S
Pathol Oncol Res; 2021; 27():613099. PubMed ID: 34257582
[No Abstract] [Full Text] [Related]
40. [Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Wang J; Li Q; Cheng X; Xiong K; Qi Q; Huang W
Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):874-8. PubMed ID: 26888504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
